Bryan T. Vaughn's most recent trade in Laboratory Corp. Of America Holdings was a trade of 1,584 Common Stock done . Disclosure was reported to the exchange on March 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 1,584 | 7,196 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.38 per share. | 26 Mar 2026 | 451 | 6,745 (0%) | 0% | 268.4 | 121,039 | Common Stock |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 2,200 | 2,200 | - | - | Non-qualified Stock Options | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 730 | 4,354 | - | - | Restricted Stock Unit | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 180 | 5,326 (0%) | 0% | - | Common Stock | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 180 | 3,802 | - | - | Restricted Stock Unit | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 178 | 3,624 | - | - | Restricted Stock Unit | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2026 | 178 | 5,443 (0%) | 0% | - | Common Stock | |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 274.02 per share. | 06 Feb 2026 | 61 | 5,382 (0%) | 0% | 274.0 | 16,715 | Common Stock |
| Labcorp | Bryan T. Vaughn | EVP, Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.20 per share. | 06 Feb 2026 | 61 | 5,265 (0%) | 0% | 277.2 | 16,909 | Common Stock |